Comparison of three risk of malignancy indices in evaluation of pelvic masses

A. P. Manjunath, Pratapkumar, K. Sujatha, R. Vani

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Objectives. The aims of this study were to validate the risk of malignancy index (RMI) incorporating menopausal status, serum Ca 125 levels, and ultrasound features for discriminating benign from malignant pelvic masses and to evaluate the performance of the three different risk of malignancy indices (RMI 1, RMI 2, and RMI 3). Methods. This is a retrospective study of 152 women admitted at Kasturba Hospital, Manipal, between January 1997 and August 1999 for surgical exploration of pelvic masses. The sensitivity, specificity, and positive predictive value of serum Ca 125 levels, ultrasound findings, and menopausal status were taken separately and combined into the Rmi 1, Rmi 2, and Rmi 3 to diagnose ovarian cancer. The risk of malignancy index is the product of menopausal score, ultrasound score, and serum Ca 125 levels. Results. The study confirms that the malignancy risk index is more accurate than the menopausal status, serum Ca 125 levels, and ultrasound features separately in diagnosing malignancy. There was no statistically significant difference in the performance of these three different malignancy risk indices in identifying malignancy. Conclusions. The risk of malignancy index is able to identify malignant and benign pelvic masses efficiently to optimize therapy. The risk of malignancy index is a simple scoring system which can be used in less specialized gynecology centers. We recommend the use of any of these risk of malignancy indices to facilitate the selection of cases for referral to an oncological unit for adequate staging and optimal debulking.

Original languageEnglish
Pages (from-to)225-229
Number of pages5
JournalGynecologic Oncology
Volume81
Issue number2
DOIs
Publication statusPublished - 01-01-2001
Externally publishedYes

Fingerprint

Neoplasms
Serum
Gynecology
Ovarian Neoplasms
Referral and Consultation
Retrospective Studies
Sensitivity and Specificity

All Science Journal Classification (ASJC) codes

  • Oncology
  • Obstetrics and Gynaecology

Cite this

Manjunath, A. P. ; Pratapkumar ; Sujatha, K. ; Vani, R. / Comparison of three risk of malignancy indices in evaluation of pelvic masses. In: Gynecologic Oncology. 2001 ; Vol. 81, No. 2. pp. 225-229.
@article{fdb6bc1e75094faab6fb488d9635ecab,
title = "Comparison of three risk of malignancy indices in evaluation of pelvic masses",
abstract = "Objectives. The aims of this study were to validate the risk of malignancy index (RMI) incorporating menopausal status, serum Ca 125 levels, and ultrasound features for discriminating benign from malignant pelvic masses and to evaluate the performance of the three different risk of malignancy indices (RMI 1, RMI 2, and RMI 3). Methods. This is a retrospective study of 152 women admitted at Kasturba Hospital, Manipal, between January 1997 and August 1999 for surgical exploration of pelvic masses. The sensitivity, specificity, and positive predictive value of serum Ca 125 levels, ultrasound findings, and menopausal status were taken separately and combined into the Rmi 1, Rmi 2, and Rmi 3 to diagnose ovarian cancer. The risk of malignancy index is the product of menopausal score, ultrasound score, and serum Ca 125 levels. Results. The study confirms that the malignancy risk index is more accurate than the menopausal status, serum Ca 125 levels, and ultrasound features separately in diagnosing malignancy. There was no statistically significant difference in the performance of these three different malignancy risk indices in identifying malignancy. Conclusions. The risk of malignancy index is able to identify malignant and benign pelvic masses efficiently to optimize therapy. The risk of malignancy index is a simple scoring system which can be used in less specialized gynecology centers. We recommend the use of any of these risk of malignancy indices to facilitate the selection of cases for referral to an oncological unit for adequate staging and optimal debulking.",
author = "Manjunath, {A. P.} and Pratapkumar and K. Sujatha and R. Vani",
year = "2001",
month = "1",
day = "1",
doi = "10.1006/gyno.2001.6122",
language = "English",
volume = "81",
pages = "225--229",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "2",

}

Manjunath, AP, Pratapkumar, Sujatha, K & Vani, R 2001, 'Comparison of three risk of malignancy indices in evaluation of pelvic masses', Gynecologic Oncology, vol. 81, no. 2, pp. 225-229. https://doi.org/10.1006/gyno.2001.6122

Comparison of three risk of malignancy indices in evaluation of pelvic masses. / Manjunath, A. P.; Pratapkumar; Sujatha, K.; Vani, R.

In: Gynecologic Oncology, Vol. 81, No. 2, 01.01.2001, p. 225-229.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Comparison of three risk of malignancy indices in evaluation of pelvic masses

AU - Manjunath, A. P.

AU - Pratapkumar,

AU - Sujatha, K.

AU - Vani, R.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Objectives. The aims of this study were to validate the risk of malignancy index (RMI) incorporating menopausal status, serum Ca 125 levels, and ultrasound features for discriminating benign from malignant pelvic masses and to evaluate the performance of the three different risk of malignancy indices (RMI 1, RMI 2, and RMI 3). Methods. This is a retrospective study of 152 women admitted at Kasturba Hospital, Manipal, between January 1997 and August 1999 for surgical exploration of pelvic masses. The sensitivity, specificity, and positive predictive value of serum Ca 125 levels, ultrasound findings, and menopausal status were taken separately and combined into the Rmi 1, Rmi 2, and Rmi 3 to diagnose ovarian cancer. The risk of malignancy index is the product of menopausal score, ultrasound score, and serum Ca 125 levels. Results. The study confirms that the malignancy risk index is more accurate than the menopausal status, serum Ca 125 levels, and ultrasound features separately in diagnosing malignancy. There was no statistically significant difference in the performance of these three different malignancy risk indices in identifying malignancy. Conclusions. The risk of malignancy index is able to identify malignant and benign pelvic masses efficiently to optimize therapy. The risk of malignancy index is a simple scoring system which can be used in less specialized gynecology centers. We recommend the use of any of these risk of malignancy indices to facilitate the selection of cases for referral to an oncological unit for adequate staging and optimal debulking.

AB - Objectives. The aims of this study were to validate the risk of malignancy index (RMI) incorporating menopausal status, serum Ca 125 levels, and ultrasound features for discriminating benign from malignant pelvic masses and to evaluate the performance of the three different risk of malignancy indices (RMI 1, RMI 2, and RMI 3). Methods. This is a retrospective study of 152 women admitted at Kasturba Hospital, Manipal, between January 1997 and August 1999 for surgical exploration of pelvic masses. The sensitivity, specificity, and positive predictive value of serum Ca 125 levels, ultrasound findings, and menopausal status were taken separately and combined into the Rmi 1, Rmi 2, and Rmi 3 to diagnose ovarian cancer. The risk of malignancy index is the product of menopausal score, ultrasound score, and serum Ca 125 levels. Results. The study confirms that the malignancy risk index is more accurate than the menopausal status, serum Ca 125 levels, and ultrasound features separately in diagnosing malignancy. There was no statistically significant difference in the performance of these three different malignancy risk indices in identifying malignancy. Conclusions. The risk of malignancy index is able to identify malignant and benign pelvic masses efficiently to optimize therapy. The risk of malignancy index is a simple scoring system which can be used in less specialized gynecology centers. We recommend the use of any of these risk of malignancy indices to facilitate the selection of cases for referral to an oncological unit for adequate staging and optimal debulking.

UR - http://www.scopus.com/inward/record.url?scp=0035002871&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035002871&partnerID=8YFLogxK

U2 - 10.1006/gyno.2001.6122

DO - 10.1006/gyno.2001.6122

M3 - Article

C2 - 11330953

AN - SCOPUS:0035002871

VL - 81

SP - 225

EP - 229

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 2

ER -